Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Open Label, Active-controlled Study to Evaluate the Safety, Pharmacokinetics and Effectiveness of IV Peramivir Compared to Oral Oseltamivir in Pediatric Subjects With Acute Uncomplicated Influenza
Conditions
Interventions
Peramivir
Oseltamivir
Locations
10
United States
Peramivir Investigative Site
Shreveport, Louisiana, United States
Peramivir investigative site
Dayton, Ohio, United States
Peramivir investigative site
Smithfield, Pennsylvania, United States
Peramivir Investigative Site
Houston, Texas, United States
Peramivir investigative site
San Antonio, Texas, United States
Peramivir investigative site
Splendora, Texas, United States
Start Date
March 11, 2015
Primary Completion Date
October 28, 2019
Completion Date
May 14, 2020
Last Updated
March 23, 2021
NCT07291635
NCT06094010
NCT06417762
NCT06160128
NCT07396428
NCT07310472
Lead Sponsor
BioCryst Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions